23 August 2023

Field Safety notification regarding medical devices and pharmaceutical products

Reference: CIR-2023-00000148

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

 

Circular No.7422 for the year 2023 regarding field safety corrective action for medical devices

Suspension and Recall of the Medical Product Adakveo (crizanlizumab)

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

FSN Weekly update 21 Aug 2023.pdf:

View Document

Adakveo (crizanlizumab ).pdf:

View Document